KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Pacific Biosciences Of California (PACB) over the last 15 years, with Q3 2025 value amounting to $1.1 million.

  • Pacific Biosciences Of California's Change in Inventory rose 17705.75% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 13363.61%. This contributed to the annual value of $8.3 million for FY2024, which is 3988.87% down from last year.
  • Pacific Biosciences Of California's Change in Inventory amounted to $1.1 million in Q3 2025, which was up 17705.75% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Change in Inventory ranged from a high of $13.3 million in Q1 2023 and a low of -$9.0 million during Q4 2023
  • Moreover, its 5-year median value for Change in Inventory was $3.1 million (2023), whereas its average is $3.9 million.
  • Per our database at Business Quant, Pacific Biosciences Of California's Change in Inventory soared by 188865.25% in 2022 and then plummeted by 18547.3% in 2023.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Change in Inventory stood at $7.7 million in 2021, then soared by 37.66% to $10.5 million in 2022, then plummeted by 185.47% to -$9.0 million in 2023, then grew by 21.47% to -$7.1 million in 2024, then surged by 114.96% to $1.1 million in 2025.
  • Its Change in Inventory was $1.1 million in Q3 2025, compared to $1.3 million in Q2 2025 and $2.5 million in Q1 2025.